CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- A new TransUnion (NYSE:TRU) study reveals a significant gap between insurers' perceptions and consumer experience. While 70% of insurers say they deliver personalized experiences, only 43% of consumers agree. The disconnect is even more pronounced among Gen Z, with just 32% reporting personalized experiences. TransUnion presented the research at its recent Insurance Summit, which brought together 112 insurance professionals. "Persistent inflation has heightened consumers' focus on price and value," said Patrick Foy, senior director of strategic planning for TransUnion's insurance business. "When customers don't feel engaged through personalizati
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Seven in 10 Insurers Say They Deliver Personalized Experiences; Fewer Than Half of Consumers Agree
- IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
Transaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previously AnnouncedTORONTO and GLIL YAM, Israel, June 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the Company's Chief Executive Officer, a director and debtholder of IMC ("Slil"), purs
- BioHarvest Sciences to Present at the 2026 BIO International Convention
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ:BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details:Session: Company PresentationDate/Time: Wednesday, June 24, 11:45 AMLocation: Theater 3BioHarvest Sciences' presentation will showcase its proprietary Botanical Synthesis™ platform, which enables the production of plant-derived compounds with pharmaceutical-grade precision, consistency, and commercial scalability,
- DIAMONDROCK HOSPITALITY ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
BETHESDA, Md., June 18, 2026 /PRNewswire/ -- DiamondRock Hospitality Company (the "Company") will report financial results for the second quarter 2026 after the market closes on Thursday, July 30, 2026. The Company will hold a conference call to discuss its second quarter financial results and business outlook on Friday, July 31, 2026, at 10:00 a.m. Eastern Time (ET). The conference call will be accessible by telephone and through the internet. Interested individuals are requested to register for the call using this link to obtain dial-in and webcast details. Registration details are also available by visiting https://investor.
- Dragonfly Energy Strengthens IP Portfolio for Solid-State Battery Manufacturing with U.S. Patent Allowance
RENO, Nev., June 18, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and maker of Battle Born Batteries®, today announced it has received a notice of allowance from the United States Patent and Trademark Office for its patent application titled "Powderized Solid-State Electrolyte and Electroactive Materials." The allowed patent application is directed toward manufacturing processes that support Dragonfly Energy's solid-state battery development efforts. The technology further strengthens the Company's U.S. intellectual property position in advanced battery cell manufacturing. "This U.S. pat
- Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection
BRECKENRIDGE, Colo., June 18, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), today announced the limited release of its Breckenridge Distillery Single Barrel Bourbon Collection. These single barrel releases are an invitation to experience Breckenridge Bourbon in its most honest form; unblended, thoughtfully proofed, and defined by the barrel itself. Each barrel was hand-selected for its ability to stand entirely on its own, showcasing flavors that are complete, balanced, and compelling. All twelve expressions are aged a minimum of five years, developing depth and c
- QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier
Nes Ziona, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced a major technical and strategic milestone: the Company has successfully produced a cryogenic chip carrier using its proprietary single-build AME process, based on a design supplied by one of the world's largest U.S.-based technology companies developing full-stack quantum computing systems. The achievement expands QTREX's role within the quantum hardware stack into the processor-interface layer, demonstrating that the Company's AME platform can addres
- NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
Filed applications include claims directed to the use of EL-22 and EL-32 for preserving lean muscle mass during GLP-1 and obesity-related weight lossFiled applications include combination and co-administration approaches, including taking EL-22 or EL-32 together with apelin or ursolic acid, compounds associated with muscle support NEWPORT BEACH, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ:ELAB) ("PMGC" or the "Company") today announced that its wholly-owned subsidiary, NorthStrive Biosciences, Inc. ("NorthStrive"), has filed two new U.S. patent applications expanding the Company's EL-22 and EL-32 intellectual property portfolio into potential human pharmaceutical
- Roadzen Expands U.S. Footprint with $1.2 Million Embedded Roadside Contract
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (NASDAQ:RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance and mobility, today announced that its wholly owned U.S. roadside assistance subsidiary, National Automobile Club (NAC), has signed a commercial contract valued at approximately $1.2 million in annual revenue with a U.S. provider of digital assistance, mass insurance, and extended warranty programs. The agreement names NAC as the exclusive roadside assistance provider embedded within the client's consumer mobile application, serving a base of more than 500,000 users. The contract reflects a structural shift in how roadside assistance is
- Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced its plan to host a 2026 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule (TRiM™) platform. Each webinar in the Summer Series will focus on a specific therapeutic area and will feature presentations by Arrowhead team members about the company's clinical candidates and external key opinion leaders, who will discuss the respective disease areas and treatment landscapes. Part I of Arrowhead's 2026 Summer Series of R&D Webinars will focus on Arrowhead's cardiometabolic pipeline and will be held on June 29, 2026,
- Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutionsINDIANAPOLIS, June 18, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance innovation in animal health. To be backed by a $25 million multi-year commitment, Elanco Ventures will initially focus on strategic investments in therapeutic advancements and supportive technologies across the animal health sector."From pets to protein – the animal health industry has
- enCore Energy Receives Bureau of Land Management Authorization to Begin Construction at Dewey Burdock Uranium Project
NASDAQ: EUTSXV: EUwww.encoreuranium.comDALLAS, June 18, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ:EU) (TSXV:EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced that the Bureau of Land Management ("BLM") has issued a final decision and approved the Dewey Burdock Uranium Project, authorizing the Company to commence infrastructure construction for the Dewey Burdock Uranium In-Situ Recovery (ISR) Project in Southwest South Dakota. With the execution of the final Environmental Assessment (EA) and Finding of No Significant Impact, the BLM authorizes enCore's wholly owned subsidiary Powertech Inc.
- VinFast VF 8: The Electric SUV That Puts Family First
IRVINE, Calif., June 18, 2026 /PRNewswire/ -- There's a particular kind of exhaustion that comes with long family road trips. The engine drone that creeps into your skull somewhere around hour three. The faint smell of gasoline that lingers after every fuel stop. The constant mental load of monitoring traffic, adjusting cruise control, and trying to hold a conversation at the same time. Most families have simply accepted this as the price of getting somewhere together. VinFast thinks differently.The VF 8, the Vietnamese automaker's flagship electric SUV now available across the United States, is built around a straightforward p
- $242.3 Million USD in Total Construction Value; PowerBank Confirms Safe Harbor of 23 Distributed Solar and Energy Storage Projects
$94.7 Million USD Estimated Combined Value of Potential Tax Credits97 MW DC of Solar and 42 MWh of Energy Storage Across New York and PennsylvaniaProjects Expected to Power Equivalent of 11,000 HomesTORONTO, June 18, 2026 /PRNewswire/ - PowerBank Corporation (NASDAQ:PBK) (Cboe CA: PBK) (FSE: 103) ("PowerBank" or the "Company"), a leader in independent energy development and asset ownership in North America, is pleased to confirm the completion of equipment procurement agreements totaling $242.3 million USD in construction value across 23 distributed solar and energy storage projects (the "Projects") in New York and Pennsylvania through its wholly owned subsidiary Abundant Solar Power Inc. Th
- AIRO Debuts RQ-70 Long-Range ISR Drone Platform at Eurosatory 2026, Advancing Multi-Product Growth Strategy
AIRO Group Holdings, Inc. (NASDAQ:AIRO), a next-generation aerospace and defense company, in combination with Sky-Watch A/S, its wholly owned subsidiary, today announced the public unveiling of its RQ-70, a new deep-reach intelligence, surveillance and reconnaissance (ISR) drone, extending ISR capabilities beyond the immediate tactical frontline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618945644/en/RQ-70 The announcement was made at Eurosatory 2026, a global event for defense and security held in Paris. AIRO expects the RQ-70 to enter full-scale production in January 2027, leveraging the Company's existing manufactur
- Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlate™ XM Dynamic Compression Locking Implant. HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the titanium compression implants to deliver rapid insertion and dynamic compression across the fusion site with enhanced multiplanar strength and stability. The HyperPlate™ XM Dynamic Com
- HIVE's BUZZ HPC Closes USD $220 Million Sovereign AI GPU Contract with Bell AI Fabric for Cohere Inc.
This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated June 16, 2026 to its short form base shelf prospectus dated October 31, 2025.Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - HIVE Digital Technologies Ltd. (TSX:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), through its wholly owned subsidiary BUZZ High Performance Computing Inc. ("BUZZ HPC"), today announced a landmark sovereign AI infrastructure deal involving Bell Canada (TSX:BCE) (NYSE:BCE) and Cohere Inc., marking a significant milestone in Canada's AI infrastructure ecosystem.The collaboration brings togeth
- Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora's ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis PigmentosaEncinitas, California--(Newsfile Corp. - June 18, 2026) - Kiora Pharmaceuticals (NASDAQ:KPRX) today announced preclinical data showing that KIO-300, part of the company's novel ion channel modulator platform, significantly suppressed seizure-associated electrophysiological activity in an ex vivo temporal lobe epilepsy (TLE) model. The findings were presented in a poster at the Epilepsy Foundatio
- Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in Phio Pharmaceuticals, to attend the live, interactive presentation and one-on-one meetingsKing of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762 for the treatment of cutaneous c
- Wayfair Expands Northeast Footprint with Princeton, New Jersey Store
BOSTON, June 18, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced plans to open a new large-format retail store in Princeton, New Jersey. The location, expected to open in 2027, marks an important step in expanding Wayfair's presence across the Northeast and serving customers throughout New Jersey, New York and Pennsylvania. "Opening in Princeton represents another exciting milestone as we continue expanding Wayfair's physical retail presence across America," said Liza Lefkowski, vice president of merchandising and stores at Wayfair. "We're creating a destination where customers can explore inspiring spaces, experience the quality and breadth o